대장암의 근치적 절제술 후 발생한 복막 재발의 위험 인자

다국어 초록 (Multilingual Abstract)

Purpose: Peritoneal recurrence after curative resection of colorectal cancer has been considered to be a lethal condition and to be suitable for palliative chemotherapy. Recently, aggressive approaches such as cytoreductive surgery and perioperative intraperitoneal chemotherapy were introduced for peritoneal malignancies to improve survival. The aim of this study is to identify the risk factors of peritoneal recurrence after curative resection of colorectal cancer and to determine the indication of early postoperative intraperitoneal chemotherapy (EPIC).
Methods: From January 1997 to December 2007, a total of 2,320 patients’ records with curative resection for colorectal cancer were collected through the prospective colorectal cancer registry protocol in Kyungpook National University Hospital, Korea. Of those, a total of 1,929 patients were included for analysis of the relationship between perioperative clinicopathologic variables and peritoneal recurrence.
Results: The study group was composed of 1,086 men and 843 women with a mean age of 61.1. In multivariate analysis, preoperative level of serum CA19-9＞37 U/㎖ (odd ratio [OR] 3.217; 95% confidence interval [95% CI] 1.525∼6.788), right colon cancer (OR 2.524; 95% CI 1.158∼5.502), pT4 tumor (OR 2.131; 95% CI 1.009∼4.502) and positive apical lymph node (OR 3.045; 95% CI 1.023∼9.066) were independent risk factors of peritoneal recurrence after curative resection of colorectal cancer.
Conclusion: In colorectal cancer patients with increased preoperative serum levels of CA19-9, right-sided location, serosal exposure or invasion of adjacent organ, and positive apical lymph node, more scrupulous surveillance for peritoneal recurrence was necessary during the postoperative follow-up period. In selective patients with risk factors of peritoneal recurrence, more aggressive strategies for management, such as EPIC, were able to be considered under the acceptable general condition and life-expectancy.

목차 (Table of Contents)

• 서론
• 방법
• 결과
• 고찰
• 결론
• REFERENCES

참고문헌 (Reference)

1 Speyer JL, "The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies" 12 : 23-28, 1985

2 Yan TD, "Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma" 24 : 4011-4019, 2006

3 Sugarbaker PH, "Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment" 373 : 189-196, 1988

4 Gilbert JM, "Sites of recurrent tumour after ‘curative' colorectal surgery: implications for adjuvant therapy" 71 : 203-205, 1984

5 Yang SH, "Risk factors for peritoneal dissemination of colorectal cancer" 87 : 167-173, 2004

6 Verwaal VJ, "Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer" 21 : 3737-3743, 2003

7 Speyer JL, "Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans" 41 : 1916-1922, 1981

8 Jacquet P, "Peritoneal-plasma barrier" 82 : 53-63, 1996

9 Brodsky JT, "Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy" 34 : 723-727, 1991

10 Koppe MJ, "Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies" 243 : 212-222, 2006

11 Chu DZ, "Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors" 63 : 364-367, 1989

12 Sadeghi B, "Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study" 88 : 358-363, 2000

13 Jayne DG, "Peritoneal carcinomatosis from colorectal cancer" 89 : 1545-1550, 2002

14 Cass AW, "Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum" 37 : 2861-2865, 1976

15 Hartley JE, "Patterns of recurrence and survival after laparoscopic and conventional resections for colorectal carcinoma" 232 : 181-186, 2000

16 Galandiuk S, "Patterns of recurrence after curative resection of carcinoma of the colon and rectum" 174 : 27-32, 1992

17 Noura S, "Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection" 52 : 1312-1320, 2009

18 Japanese Society for Cancer of the Colon and Rectum, "Japanese Classification of Colorectal Carcinoma" Kanehara & Co., Ltd. 1997

19 de Bree E, "Intraperitoneal chemotherapy for colorectal cancer" 79 : 46-61, 2002

20 Sugarbaker PH, "Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis" 14 : 254-261, 1998

21 Obrand DI, "Incidence and patterns of recurrence following curative resection for colorectal carcinoma" 40 : 15-24, 1997

22 Manfredi S, "Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population" 93 : 1115-1122, 2006

23 Glehen O, "Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study" 22 : 3284-3292, 2004

24 Spratt JS, "Clinical delivery system for intraperitoneal hyperthermic chemotherapy" 40 : 256-260, 1980

25 Malcolm AW, "Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum" 152 : 131-136, 1981

26 Vaillant JC, "Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: a multicenter phase III trial" 231 : 449-456, 2000

27 Graf W, "Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study" 9 : 35-39, 1994

28 Russell AH, "Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies" 56 : 1446-1451, 1985

29 Yu W, "A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy" 32 : 655-660, 2006